Navigation Links
Chronic disease research awarded funding
Date:1/15/2013

A new initiative to understand chronic disease in Africa has been awarded five years' funding by the Medical Research Council (MRC). The African Partnership for Chronic Disease Research (APCDR) is an international research partnership that assesses the burden and causes of non-communicable diseases such as diabetes and heart disease in sub-Saharan Africa.

This MRC funding will allow researchers from the partnership to develop a sustainable platform to share resources and skills which will help develop long-term strategies for disease control and management in sub-Saharan Africa.

As treatment and management of infectious diseases such as HIV, malaria and tuberculosis improves, medical researchers expect that non-infectious chronic diseases will become an increasingly important problem in sub-Saharan Africa. Diseases such as type 2 diabetes and cardiovascular disease are expected to become the leading causes of morbidity and death in this region.

The APCDR will conduct research that will provide more reliable and precise information on disease burden, underlying aetiology and strategies for intervention.

"We don't fully understand the magnitude and distribution of risk factors for these diseases in sub-Saharan Africa," says Dr Elizabeth Young, investigator from the Wellcome Trust Sanger Institute. "Over the next five years, our partnership expects to collect detailed health and disease information and blood samples from over 24,000 individuals across 10 countries. This collection will generate a resource that will provide a unique framework for researchers in these countries."

In existing studies into these diseases throughout Africa, scientists have used a variety of methods and assessed only a small subset of risk factors. This small scale restricts any comparative studies across the region.

This partnership will develop the much needed, large-scale high quality comparable studies across a wide range of di
'/>"/>

Contact: Aileen Sheehy
press.office@sanger.ac.uk
0044-012-234-92368
Wellcome Trust Sanger Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Genetic mutation found in familial chronic diarrhea syndrome
2. Effect of chronic exposure to chemicals used as weapons, pesticides under study
3. BYU engineers conceive disc replacement to treat chronic low back pain
4. Neuroprotective dietary supplements for chronic spinal cord injury
5. Why chronic pain is all in your head
6. Chronic inflammation in the brain leads the way to Alzheimers disease
7. miR loss may power maligant transformation in chronic leukemia
8. How chronic obstructive pulmonary disease increases risk of lung cancer
9. Basal cell carcinoma risk can be chronic
10. Chronic 2000-04 drought, worst in 800 years, may be the new normal
11. Bacteria-immune system fight can lead to chronic diseases, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... Washington, D.C. (April 5, 2011) -- Sealants, like weather ... of a building, byproviding a barrier that prevents water ... out. The challenge, says research chemist Christopher White of ... Gaithersburg, Maryland, is predicting when they will fail. ...
... Spanish . Genetadi Biotech has presented to ... on Human Genetics held in Murcia - a prenatal diagnostic ... microarray technology (genomic hybridisation genetic chips) and with a diagnostic ... new device, known as Amniochip, is able to detect 150 ...
... our two closest living primate relatives, chimpanzees and bonobos, ... same genus. Now, a comparative analysis of their ... these behaviors, from the aggression more typical of chimpanzees ... is that the data appears to match what we ...
Cached Biology News:Inexpensive new instruments test building sealants under real-world conditions 2New technology capable of detection of 150 genetic syndromes from an amniocentesis 2Chimp, bonobo study sheds light on the social brain 2
(Date:8/4/2015)... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... , today announced that it will release its unaudited ... 2015, after market close on Wednesday, August 12, 2015. The ... 13, 2015, at 8:00 a.m. EDT (Thursday, August 13, ... the Company,s financial results and provide an update on ...
(Date:8/3/2015)... MARIETTA, Ga. , Aug. 3, 2015  MiMedx ... medicine company utilizing human amniotic tissue and patent-protected processes ... the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic ... will present at the 35 th Annual Canaccord|Genuity ...  Parker H. "Pete" Petit, Chairman and CEO, William ...
(Date:8/3/2015)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), the ... diseases, today announced that it will host its First ... Thursday, August 13, 2015 at 4:30 p.m. Eastern Time. ... release of fiscal 2016 first quarter results.  A recorded ... hours after the call at the Investor Relations portion ...
(Date:8/3/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a ... autologous cell therapies, announced today that RepliCel,s CEO, David ... in Minneapolis, Minnesota on August 5 ... highlight RepliCel,s 18-month milestones including CE Mark for its RCI-02 ... clinical data from both RCT-01 (tendon) and RCS-01 (skin) clinical ...
Breaking Biology Technology:Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2
... 2010 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... breakthrough treatments for human disease, today updated the progress ... for the three and nine months ended September 30, ... new mechanisms of action in irritable bowel syndrome and ...
... 5, 2010 Tomophase Corporation, a leading developer of ... announced that it has received an award from the ... for the Qualifying Therapeutic Discovery Project (QTDP.) ... sponsored program that is targeted to projects that show ...
... today released the first in a series of video ... technology correspondent Miles O,Brien and currently airing nationally on ... quick look at what happens when genius meets possibility: ... shaping our world. The 26-part video series is ...
Cached Biology Technology:Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 2Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 3Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 4Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 5Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 6Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 7Tomophase Receives Qualifying Therapeutic Discovery Project (QTDP) Award 2
Incomplete Adjuvant...
The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Biology Products: